What are the adverse effects of infliximab in the treatment of hidradenitis suppurativa (HS)?

Updated: Nov 20, 2020
  • Author: Marina Jovanovic, MD, PhD; Chief Editor: William D James, MD  more...
  • Print

The existing prospective studies have described variable patient responses and significant adverse reactions, including hypersensitive reactions, lupuslike reactions, and abdominal pain secondary to colon cancer, tuberculosis, and motor neuropathy. The studies varied in their outcome assessment, population studied, and dose of infliximab used in patients with hidradenitis suppurativa. [115] In a study in the United Kingdom, the authors looked at 134 responses to an online survey of dermatology consultants, nurses, and general practitioners who treat patients with hidradenitis suppurativa, in order to see how much variation there is in the types of treatment patients receive; 46% of responders included infliximab in their top 10 treatments. [116] Moderate-quality evidence suggests that infliximab is effective in hidradenitis suppurativa. [117]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!